ArticleMikrochimica acta2026
Optimized hexamine-derived carbonized polymer dots as fluorescent nanoswitches for precision spectral imaging sensing of glucocorticoids.
Article in Mikrochimica acta, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The synthesis is presented of highly fluorescent hexamine-derived carbonized polymer dots (HACDs), which are made possible by ethylenediamine and folic acid. Density functional theory is used to clarify the formation mechanism and optimize the electronic structure of HACDs that resemble polymers. Our study reveals effective intramolecular charge transfer pathways and a favorable reaction coordinate, supported by electrostatic potential mapping and HOMO-LUMO transitions. The resulting HACDs have a ∼3.3 eV optical bandgap, an extraordinary quantum yield of 80.1%, and aggregation-induced, dual-emissive, excitation-independent fluorescence, a property that enables self-calibrated readouts. This dual emission reduces interference from environmental fluctuations (pH, polarity), thereby improving reliability in practical biosensing and bioimaging applications. We confirm the nitrogen doping and excellent photostability through spectroscopic studies over a 90-day duration. The emission quenching represented by HACD was used to determine hydrocortisone and prednisolone quantitatively to examine their biosensing capacity. The negligible toxicity was displayed by the MTT assay on V79 fibroblast cells to confirm the safe biological use of HACD as a nontoxic fluorescence sensor. The obtained results established that the HACDs have potential for the selective detection of glucocorticoids for biomolecular sensing.
Indexed as
Identifiers
41507658What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.